Archive Newsletter
-
07.06.26 -- In An Era Of Overcapacity, Should Companies Rent, Lease, Or Build Their Manufacturing Future?
7/6/2026
07/06/26 Cell & Gene Newsletter
-
07.03.26 -- Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains
7/3/2026
07/03/26 Cell & Gene Newsletter
-
07.02.26 -- New Podcast Episodes: A Midyear Look At Life Sciences, Derisking CNS Drug Development, In Vivo Gene Editing
7/2/2026
07/02/26 Cell & Gene Newsletter
-
07.02.26 -- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
7/2/2026
07/02/26 Cell & Gene Newsletter
-
07.01.26 -- In Vivo Gene Editing Is Moving From Promise To Proof
7/1/2026
07/01/26 Cell & Gene Newsletter
-
06.30.26 -- Cell Therapy Without The Cells: Building A Therapeutic Secretome
6/30/2026
06/30/26
-
06.30.26 -- Better IDS Workflows Start Here
6/30/2026
06/30/26 Cell & Gene Newsletter
-
06.30.26 -- PUPSIT In Cell & Gene Therapy: Risk Reduction Or Operational Complexity?
6/30/2026
06/30/26 Cell & Gene Newsletter
-
06.29.26 -- Simplify The Journey Of Advancing Your Therapies To Patients
6/29/2026
06/29/26 Cell & Gene Newsletter
-
06.29.26 -- May 2026 — CDMO Opportunities And Threats Report
6/29/2026
06/29/26 Cell & Gene Newsletter